Cargando…

Local production of soluble CD163 in the spondyloarthropathic joint

Detalles Bibliográficos
Autores principales:	Baeten, D, Møller, HJ, Delanghe, J, Veys, EM, Moestrup, SK, De Keyser, F
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833657/ http://dx.doi.org/10.1186/ar720

Ejemplares similares

Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy
por: Baeten, D, et al.
Publicado: (2001)

Soluble ectodomain CD163 and extracellular vesicle-associated CD163 are two differently regulated forms of ‘soluble CD163’ in plasma
por: Etzerodt, Anders, et al.
Publicado: (2017)

The presentation of the immunodominant epitope of HC gp-39 in the context of the RA-associated HLA class II molecules is specific for RA synovium
por: Baeten, D, et al.
Publicado: (2003)

Myeloid-related protein (MRP) 8 and MRP 14 in rheumatoid arthritis and spondyloarthropathy
por: De Rycke, L, et al.
Publicado: (2003)

Soluble haemoglobin scavenger receptor (sCD163): a marker associated with bacteraemia
por: Gaïni, S, et al.
Publicado: (2005)

The diagnostic value of synovial histopathology in undifferentiated inflammatory arthritis: a prospective study in 154 consecutive patients
por: Baeten, D, et al.
Publicado: (2003)

Differential expression and response to infliximab treatment of specific macrophage subsets in inflammatory synovitis
por: De Rycke, L, et al.
Publicado: (2004)

The effect of infliximab on skin lesions in a patient with scleroderma (CREST)
por: De Rycke, L, et al.
Publicado: (2004)

Serum MRP8/MRP14 as a biomarker for inflammation in autoimmune arthritis
por: De Rycke, L, et al.
Publicado: (2004)

Localisation of MHC Class II/HC gp-39 complexes in synovia of rheumatoid arthritis patients using complex-specific monoclonal antibodies
por: Baeten, D, et al.
Publicado: (2003)

Sensitivity of ANA indirect immunofluorescence testing for the detection of anti-ENA antibodies
por: Hoffman, IEA, et al.
Publicado: (2002)

The effect of infliximab on rheumatoid factor and anti-citrullinated cyclic peptide antibodies
por: van Damme, N, et al.
Publicado: (2002)

Induction of ANA, anti-dsDNA and anti-nucleosome antibodies following infliximab treatment in rheumatoid arthritis and spondyloarthropathy patients
por: de Rycke, LEB, et al.
Publicado: (2002)

Changes in rheumatoid factor reflect the inflammatory response (CRP and ESR) to infliximab treatment
por: De Rycke, L, et al.
Publicado: (2003)

Drug Trafficking into Macrophages via the Endocytotic Receptor CD163
por: Graversen, Jonas Heilskov, et al.
Publicado: (2015)

Targeting of CD163(+) Macrophages in Inflammatory and Malignant Diseases
por: Skytthe, Maria K., et al.
Publicado: (2020)

Diagnostic performance and predictive value of serum markers for the diagnosis of rheumatoid arthritis
por: Hoffman, IEA, et al.
Publicado: (2004)

Presence of anti-RNP-A and anti-RNP-C antibodies is inversely associated with renal symptoms of systemic lupus erythematosus
por: Hoffman, I, et al.
Publicado: (2003)

False positivity of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus
por: Hoffman, IEA, et al.
Publicado: (2004)

Soluble CD 163: A novel biomarker
por: Ahuja, Rajeev B.
Publicado: (2011)

The Haptoglobin-CD163-Heme Oxygenase-1 Pathway for Hemoglobin Scavenging
por: Thomsen, Jens Haugbølle, et al.
Publicado: (2013)

Mouse CD163 deficiency strongly enhances experimental collagen-induced arthritis
por: Svendsen, Pia, et al.
Publicado: (2020)

Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis
por: Gantzel, Rasmus Hvidbjerg, et al.
Publicado: (2021)

The use of neural network algorithms for the classification of undifferentiated arthritis by synovial histopathology
por: Baeten, D, et al.
Publicado: (2003)

The presence of deiminated fibrin in the synovial membrane is not specific for rheumatoid arthritis
por: Chapuy-Regaud, S, et al.
Publicado: (2004)

Covariation of MHC class I and CD163 positive macrophages in skeletal muscle tissue of polymyositis and dermatomyositis patients after treatment with high-dose intravenous immunoglobulin (IVIg)
por: Barbasso, S, et al.
Publicado: (2003)

Clinical Significance of Soluble Hemoglobin Scavenger Receptor CD163 (sCD163) in Sepsis, a Prospective Study
por: Feng, Lin, et al.
Publicado: (2012)

Soluble CD163 and CD163 Expression on Monocytes Associated with Chronic Hepatitis B Inflammation and HBsAg Loss
por: Xie, Peilin, et al.
Publicado: (2022)

Soluble CD163 correlates with lipid metabolic adaptations in type 1 diabetes patients during ketoacidosis
por: Svart, Mads, et al.
Publicado: (2018)

Soluble CD163 as a Potential Biomarker in Systemic Sclerosis
por: Frantz, Camelia, et al.
Publicado: (2018)

Soluble CD163 in intracerebral hemorrhage: biomarker for perihematomal edema
por: Roy‐O'Reilly, Meaghan, et al.
Publicado: (2017)

Soluble CD163 as a Marker of Macrophage Activity in Newly Diagnosed Patients with Multiple Sclerosis
por: Stilund, Morten, et al.
Publicado: (2014)

Anti-CD163-dexamethasone protects against apoptosis after ischemia/reperfusion injuries in the rat liver
por: Møller, Lin Nanna Okholm, et al.
Publicado: (2015)

Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma
por: Vajavaara, Heli, et al.
Publicado: (2021)

Soluble CD163 Changes Indicate Monocyte Association With Cognitive Deficits in Parkinson's Disease
por: Nissen, Sara Konstantin, et al.
Publicado: (2020)

Monocyte Expression and Soluble Levels of the Haemoglobin Receptor (CD163/sCD163) and the Mannose Receptor (MR/sMR) in Septic and Critically Ill Non-Septic ICU Patients
por: Kjærgaard, Anders G., et al.
Publicado: (2014)

Soluble CD163-Associated Dietary Patterns and the Risk of Metabolic Syndrome
por: Hu, Tzu-Yu, et al.
Publicado: (2019)

Utility of Soluble CD163 in the Clinical Management of Patients With Kawasaki Disease
por: Azuma, Yoshihiro, et al.
Publicado: (2020)

Soluble CD163 Is a Predictor of Mortality in Patients With Decompensated Cirrhosis
por: Zhang, Yue, et al.
Publicado: (2021)

Targeting the Hemoglobin Scavenger receptor CD163 in Macrophages Highly Increases the Anti-inflammatory Potency of Dexamethasone
por: Graversen, Jonas H, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_i910ej31jpkc1ocj8vmnlaqg17